Teva Pharmaceutical Industries Ltd ADR buy Truist Financial Co.
Start price
29.01.26
/
50%
€27.00
Target price
29.01.27
€31.75
Performance (%)
-1.85%
Price
09.04.26
€26.50
Summary
This prediction is currently active. With a performance of -1.85%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 29.01.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 0.383% | 0.383% |
| iShares Core DAX® | 3,01 % | 1,44 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % |
| iShares S&P 500 | 2,38 % | 0,24 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Truist Financial Corporation from $36.00 to $38.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€28.90
18.02.26
18.02.26
€35.46
18.02.27
18.02.27
-8.30%
09.04.26
09.04.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.95
28.05.25
28.05.25
€22.09
28.05.26
28.05.26
66.14%
09.04.26
09.04.26

